Table 1.
Clinical backgrounds of enrolled patients
| Patient no. | Age | Sex | Localization | History (years) | Previous therapy (refractoriness) | Concomitant therapy | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-ASA (mg/day) | PSL (mg/day) | AZA (mg/day) | CAP (times) | Duration (weeks) | 5-ASA (mg/day) | PSL (mg/day) | AZA (mg/day) | CAP (times) | |||||
| 1 | 68 | f | Pancolon | 3 | 3600 | 60–30 | 50 | 9 | 7 | 3600 | 25 | 50 | 0 |
| 2 | 63 | m | Rectosigmoid | 2 | 3600 | 60–40 | No | 6 | 5 | 3600 | 40 | No | 2 |
| 3 | 37 | m | Pancolon | 20 | 3600 | 60 | No | 5 | 3 | 3600 | 60–40 | No | 2 |
| 4 | 50 | f | Pancolon | 5 | 3600 | 0 | 6MP 15 | 0 | 13 | 3600 | 0 | No | 0 |
| 5 | 62 | m | Left | 1 | 3600 | 60 | No | 3 | 2 | 3600 | 60–40 | No | 0 |
| 6 | 51 | f | Left | 31 | 4000 | 60–40 | No | 4 | 3 | 4000 | 40 | No | 7 |
| 7 | 55 | f | Pancolon | 26 | SASP 4500 | 60–30 | No | 1 | 3 | SASP 4500 | 30 | No | 0 |
5-ASA 5-aminosalicylic acid, PSL prednisolone, AZA azathioprine, CAP cytapheresis